A Phase 1 Study of Bethanechol in Pancreatic Cancer
Recruiting Phase 2 NCT05241249
Study Description
Evaluating the Safety and Effectiveness of Bethanechol in Combination with Chemotherapy for Pancreatic Cancer
Study Details
- Registry ID:
- NCT05241249
- Conditions:
- Pancreas Cancer
- Phase:
- Phase 2
- Target Enrollment:
- 37 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Columbia University Medical Center
New York, New York, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.